<DOC>
<DOCNO>EP-0001255</DOCNO> 
<TEXT>
<INVENTION-TITLE>
FLUORINATED PROSTAGLANDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS A DRUG
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P4300	C07C40100	C07C40100	C07C6700	A61K31185	A61K3120	A61P4300	A61K31215	C07C40500	A61K3121	C07C6700	C07C40500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	C07C	C07C	C07C	A61K	A61K	A61P	A61K	C07C	A61K	C07C	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P43	C07C401	C07C401	C07C67	A61K31	A61K31	A61P43	A61K31	C07C405	A61K31	C07C67	C07C405	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
1. Compounds of the formula I  see diagramm : EP0001255,P17,F1  in which X and Y together denote oxygen or each denote hydrogen or a hydroxyl group, in which case X and Y are different, R**1 denotes a straight-chain, or branched alkyl radical with up to 8 carbon atoms, in which one CH2 groups is replaced by an oxygen atom, or a hydrogen atom can be replaced by a hydroxyl group, the oxygen functional group being separated by at least two carbon atoms from the carboxyl group of the prostaglandin, or a phenalkyl radical in which the alkylene group has up to 5 carbon atoms and one of the CH2 groups is replaced by an oxygen atom ; R**2 denotes a straight-chain, branched, alkyl radical with three to five carbon atoms or a cycloalkyl radical with five to seven carbon atoms and R**3 denotes hydrogen.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BARTMANN, WILHELM, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
BECK, GERARD, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
LERCH, ULRICH, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHOLKENS, BERNWARD, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
